October 25,2010
Grassley Asks FDA about Medical Device Company Payments to Doctors in Clinical Studies
WASHINGTON – On Friday, Sen. Chuck Grassley of Iowa asked the Food and Drug Administration how the agency handles reports of medical device companies' payments to doctors who are participating in clinical studies of the companies' products.
Grassley wrote to the FDA commissioner, citing information that doctors participating in clinical trials sponsored by a particular medical device maker also received significant payments from that device maker.
“The FDA should be transparent and describe what it does with information about potential conflicts of interest, including any steps it takes to protect the integrity and reliability of clinical research,” Grassley said.
Next Article Previous Article
Recent News
- Wyden Statement at Finance Committee Vote on RFK Jr.'s Nomination to be HHS Secretary
- Wyden: Trump Tariffs Will Make Everything More Expensive, Solve Zero Problems and Harm American Farmers and Small Businesses
- Wyden Slams RFK Jr.'s Failure to Answer Basic Questions on Vaccines
- Wyden Demands Answers Following Report of Musk Personnel Seeking Access to Highly Sensitive U.S. Treasury Payments System
- Wyden, Finance Democrats Press RFK Jr. to Reject Big Pharma Pause on Medicare Negotiation